APA (7th ed.) Citation

Ouyang, G., Liu, Y., Liu, J., Huang, L., Luo, F., & Li, L. (2023). Efficacy and safety of reduced‐dose chemotherapy plus immunotherapy in patients with lung squamous cell carcinoma: A real‐world observational study. Wiley.

Chicago Style (17th ed.) Citation

Ouyang, Ganlu, Yanyang Liu, Jiewei Liu, Lin Huang, Feng Luo, and Lu Li. Efficacy and Safety of Reduced‐dose Chemotherapy Plus Immunotherapy in Patients with Lung Squamous Cell Carcinoma: A Real‐world Observational Study. Wiley, 2023.

MLA (9th ed.) Citation

Ouyang, Ganlu, et al. Efficacy and Safety of Reduced‐dose Chemotherapy Plus Immunotherapy in Patients with Lung Squamous Cell Carcinoma: A Real‐world Observational Study. Wiley, 2023.